The tumor suppressor gene TP53: implications for cancer management and therapy.
about
[6]-Gingerol induces cell cycle arrest and cell death of mutant p53-expressing pancreatic cancer cellsJasmonates induce nonapoptotic death in high-resistance mutant p53-expressing B-lymphoma cellsCombination of 9-aminoacridine with Campath-1H provides effective therapy for a murine model of adult T-cell leukemiaEEF1A2 inactivates p53 by way of PI3K/AKT/mTOR-dependent stabilization of MDM4 in hepatocellular carcinoma.Targeting p53 by small molecules in hematological malignancies.Specific TP53 mutations predict aggressive phenotype in head and neck squamous cell carcinoma: a retrospective archival study.Immunoexpression and prognostic role of p53 in different subtypes of epithelial ovarian carcinomaMethyl Jasmonate: An Alternative for Improving the Quality and Health Properties of Fresh Fruits.Cysteine-conjugated metabolites of ginger components, shogaols, induce apoptosis through oxidative stress-mediated p53 pathway in human colon cancer cells.Randomized, controlled phase II study of post-surgery radiotherapy combined with recombinant adenoviral human p53 gene therapy in treatment of oral cancer.Choosing where to look next in a mutation sequence space: Active Learning of informative p53 cancer rescue mutants.Understanding the multiple biological aspects leading to myelomaSurgery combined with adenoviral p53 gene therapy for treatment of non-small cell lung cancer: a phase II study.p53 mutations may be involved in malignant transformation of giant cell tumor of bone through interaction with GPX1.[EEF1A2 inhibits the p53 function in hepatocellular carcinoma via PI3K/AKT/mTOR-dependent stabilization of MDM4].
P2860
Q24654171-AD463AD9-BA1E-4BF4-A9D2-0A477FA1131DQ24676240-836E9966-A33F-451F-ACC2-A9B3E4B65AB0Q33767881-91BA647E-F0EB-4B95-8B41-22CAD4431E9BQ33970628-FE0789BB-1876-4C10-A8E6-34C20F1556B0Q34636996-D00EA4D8-2B94-4A3C-AEE2-F7592AF9A589Q34980673-986CA17F-1202-47D7-93E5-D9161AA6EF78Q36682128-ADFE5E1F-7D46-4C1B-8A2D-F6A79283584CQ38852727-3D883AD0-7323-4C58-8192-788EAE10D516Q39939944-486612FA-F2ED-48A0-A7D7-F6C7D982A8AFQ40245935-560B4718-4328-419F-8436-494B21A444A1Q42088464-022C5553-8C2A-473A-9580-4E48B47C53D2Q42385107-657D2584-EEBE-4A2C-9F28-6AFDF0796F7BQ47122526-51B86114-A985-4DA6-ACCC-91BEA85A3D88Q50924369-4D13A15B-5067-4312-84D9-E007808AADDAQ54309795-DAEFF16F-2A17-463D-A145-38C16F6D0BB7
P2860
The tumor suppressor gene TP53: implications for cancer management and therapy.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
The tumor suppressor gene TP53: implications for cancer management and therapy.
@ast
The tumor suppressor gene TP53: implications for cancer management and therapy.
@en
type
label
The tumor suppressor gene TP53: implications for cancer management and therapy.
@ast
The tumor suppressor gene TP53: implications for cancer management and therapy.
@en
prefLabel
The tumor suppressor gene TP53: implications for cancer management and therapy.
@ast
The tumor suppressor gene TP53: implications for cancer management and therapy.
@en
P2093
P2860
P1476
The tumor suppressor gene TP53: implications for cancer management and therapy.
@en
P2093
Claude Caron de Fromentel
Daniela Maurici
Magali Olivier
Severine Seemann
P2860
P304
P356
10.1080/10408360490504952
P577
2004-01-01T00:00:00Z